{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:41:38Z","timestamp":1781678498690,"version":"3.54.5"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-018-0165-1","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T03:31:29Z","timestamp":1521775889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancer drug target identification and node-level analysis of the network of MAPK pathways"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-0980","authenticated-orcid":false,"given":"V. K. MD","family":"Aksam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M.","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9375-2177","authenticated-orcid":false,"given":"Sundaramurthy","family":"Pandurangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"165_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nbt1137","volume":"23","author":"GP Adams","year":"2005","unstructured":"Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23:1147\u20131157","journal-title":"Nat Biotechnol"},{"key":"165_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.imu.2017.08.006","volume":"9","author":"VKMD Aksam","year":"2017","unstructured":"Aksam VKMD, Chandrasekaran VM, Pandurangan S (2017) Hub nodes in the network of human mitogen-activated protein kinase (MAPK) pathways: characteristics and potential as drug targets. Inform Med Unlocked 9:173\u2013180","journal-title":"Inform Med Unlocked"},{"key":"165_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/35019019","volume":"406","author":"R Albert","year":"2000","unstructured":"Albert R, Jeong H, Barab\u00e1si A-L (2000) Error and attack tolerance of complex networks. Nature 406:378\u2013382","journal-title":"Nature"},{"key":"165_CR4","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1073\/pnas.200327197","volume":"97","author":"LAN Amaral","year":"2000","unstructured":"Amaral LAN, Scala A, Barthelemy M, Stanley HE (2000) Classes of small-world networks. Proc Natl Acad Sci 97:11149\u201311152","journal-title":"Proc Natl Acad Sci"},{"key":"165_CR5","doi-asserted-by":"publisher","first-page":"bau015","DOI":"10.1093\/database\/bau015","volume":"2014","author":"O An","year":"2014","unstructured":"An O, Pendino V, D\u2019Antonio M, Ratti E, Gentilini M, Ciccarelli FD (2014) NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database 2014:bau015","journal-title":"Database"},{"key":"165_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/138920309787847617","volume":"10","author":"MA Antal","year":"2009","unstructured":"Antal MA, Bode C, Csermely P (2009) Perturbation waves in proteins and protein networks: applications of percolation and game theories in signaling and drug design. Curr Protein Pept Sci 10:161\u2013172","journal-title":"Curr Protein Pept Sci"},{"key":"165_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25:25\u201329","journal-title":"Nat Genet"},{"key":"165_CR8","first-page":"nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2010","unstructured":"Barab\u00e1si A-L, Gulbahce N, Loscalzo J (2010) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:nrg2918","journal-title":"Nat Rev Genet"},{"key":"165_CR9","doi-asserted-by":"publisher","first-page":"16146","DOI":"10.1073\/pnas.0703894104","volume":"104","author":"M Behar","year":"2007","unstructured":"Behar M, Dohlman HG, Elston TC (2007) Kinetic insulation as an effective mechanism for achieving pathway specificity in intracellular signaling networks. Proc Natl Acad Sci 104:16146\u201316151","journal-title":"Proc Natl Acad Sci"},{"key":"165_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.283.5400.381","volume":"283","author":"US Bhalla","year":"1999","unstructured":"Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science (80-) 283:381\u2013387","journal-title":"Science (80-)"},{"key":"165_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355\u2013365","journal-title":"Nature"},{"key":"165_CR12","first-page":"6997","volume":"62","author":"MS Brose","year":"2002","unstructured":"Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R et al (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62:6997\u20137000","journal-title":"Cancer Res"},{"key":"165_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nchembio.1813","volume":"11","author":"ME Bunnage","year":"2015","unstructured":"Bunnage ME, Gilbert AM, Jones LH, Hett EC (2015) Know your target, know your molecule. Nat Chem Biol 11:368\u2013372","journal-title":"Nat Chem Biol"},{"key":"165_CR14","first-page":"319","volume":"4","author":"TR Butt","year":"1995","unstructured":"Butt TR, Karathanasi SK (1995) Transcription factors as drug targets: opportunities for therapeutic selectivity. Gene Expr 4:319\u2013336","journal-title":"Gene Expr"},{"key":"165_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75:50\u201383","journal-title":"Microbiol Mol Biol Rev"},{"key":"165_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.onc.1204105","volume":"20","author":"Y-R Chen","year":"2001","unstructured":"Chen Y-R, Shrivastava A, Tan T-H (2001) Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3\/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene 20:367","journal-title":"Oncogene"},{"key":"165_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1042\/BJ20091428","volume":"425","author":"P Cohen","year":"2010","unstructured":"Cohen P (2010) Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem J 425:53\u201354","journal-title":"Biochem J"},{"key":"165_CR18","unstructured":"Cornelius SP, Kath WL, Motter AE (2011) Controlling complex networks with compensatory perturbations. arXiv Preprint arXiv:11053726"},{"key":"165_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","volume":"138","author":"P Csermely","year":"2013","unstructured":"Csermely P, Korcsm\u00e1ros T, Kiss HJM, London G, Nussinov R (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138:333\u2013408","journal-title":"Pharmacol Ther"},{"key":"165_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrc906","volume":"2","author":"JE Darnell","year":"2002","unstructured":"Darnell JE (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740\u2013749","journal-title":"Nat Rev Cancer"},{"key":"165_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1006\/jmbi.1994.1116","volume":"236","author":"K Dejgaard","year":"1994","unstructured":"Dejgaard K, Leffers H, Rasmussen HH, Madsen P, Kruse TA, Gesser B et al (1994) Identification, molecular cloning, expression and chromosome mapping of a family of transformation upregulated hnRNP-K proteins derived by alternative splicing. J Mol Biol 236:33\u201348","journal-title":"J Mol Biol"},{"key":"165_CR22","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279\u20133290","journal-title":"Oncogene"},{"key":"165_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.2463","volume":"31","author":"J Dutkowski","year":"2013","unstructured":"Dutkowski J, Kramer M, Surma MA, Balakrishnan R, Cherry JM, Krogan NJ et al (2013) A gene ontology inferred from molecular networks. Nat Biotechnol 31:38\u201345","journal-title":"Nat Biotechnol"},{"key":"165_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0165-6147(00)01865-4","volume":"23","author":"JM English","year":"2002","unstructured":"English JM, Cobb MH (2002) Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23:40\u201345","journal-title":"Trends Pharmacol Sci"},{"key":"165_CR25","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1038\/onc.2010.310","volume":"29","author":"J Erenpreisa","year":"2010","unstructured":"Erenpreisa J, Cragg MS (2010) MOS, aneuploidy and the ploidy cycle of cancer cells. Oncogene 29:5447\u20135451","journal-title":"Oncogene"},{"key":"165_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tips.2010.07.005","volume":"31","author":"AF Fliri","year":"2010","unstructured":"Fliri AF, Loging WT, Volkmann RA (2010) Cause-effect relationships in medicine: a protein network perspective. Trends Pharmacol Sci 31:547\u2013555","journal-title":"Trends Pharmacol Sci"},{"key":"165_CR27","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2014","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H et al (2014) COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res 43:D805\u2013D811","journal-title":"Nucleic Acids Res"},{"key":"165_CR28","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2011","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A et al (2011) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100\u2013D1107","journal-title":"Nucleic Acids Res"},{"key":"165_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","volume":"287","author":"JB Gibbs","year":"2000","unstructured":"Gibbs JB (2000) Mechanism-based target identification and drug discovery in cancer research. Science (80-) 287:1969\u20131973","journal-title":"Science (80-)"},{"key":"165_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2105-11-76","volume":"11","author":"X Gong","year":"2010","unstructured":"Gong X, Wu R, Zhang Y, Zhao W, Cheng L, Gu Y et al (2010) Extracting consistent knowledge from highly inconsistent cancer gene data sources. BMC Bioinform 11:76","journal-title":"BMC Bioinform"},{"key":"165_CR31","first-page":"538","volume":"61","author":"VG Gorgoulis","year":"2001","unstructured":"Gorgoulis VG, Zacharatos P, Mariatos G, Liloglou T, Kokotas S, Kastrinakis N et al (2001) Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics. Cancer Res 61:538\u2013549","journal-title":"Cancer Res"},{"key":"165_CR32","first-page":"9","volume":"4","author":"NR Gough","year":"2011","unstructured":"Gough NR (2011) Focus issue: recruiting players for a game of ERK. Sci Signal 4:9","journal-title":"Sci Signal"},{"key":"165_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00018-008-8539-7","volume":"66","author":"SK Grant","year":"2009","unstructured":"Grant SK (2009) Therapeutic protein kinase inhibitors. Cell Mol Life Sci 66:1163\u20131177","journal-title":"Cell Mol Life Sci"},{"key":"165_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nmeth.2689","volume":"10","author":"M Griffith","year":"2013","unstructured":"Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC et al (2013) DGIdb: mining the druggable genome. Nat Methods 10:1209\u20131210","journal-title":"Nat Methods"},{"key":"165_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc1360","volume":"4","author":"A Gschwind","year":"2004","unstructured":"Gschwind A, Fischer OM, Ullrich A (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4:361\u2013370","journal-title":"Nat Rev Cancer"},{"key":"165_CR36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/aps.2014.80","volume":"35","author":"R He","year":"2014","unstructured":"He R, Yu Z, Zhang R, Zhang Z (2014) Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin 35:1227\u20131246","journal-title":"Acta Pharmacol Sin"},{"key":"165_CR37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682\u2013690","journal-title":"Nat Chem Biol"},{"key":"165_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5:341\u2013354","journal-title":"Nat Rev Cancer"},{"key":"165_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd2132","volume":"5","author":"P Imming","year":"2006","unstructured":"Imming P, Sinning C, Meyer A (2006) Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov 5:821\u2013834","journal-title":"Nat Rev Drug Discov"},{"key":"165_CR40","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1073\/pnas.0607595104","volume":"104","author":"A Inoue","year":"2007","unstructured":"Inoue A, Sawata SY, Taira K, Wadhwa R (2007) Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc Natl Acad Sci 104:8983\u20138988","journal-title":"Proc Natl Acad Sci"},{"key":"165_CR41","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/bioinformatics\/btl390","volume":"22","author":"PF Jonsson","year":"2006","unstructured":"Jonsson PF, Bates PA (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22:2291\u20132297","journal-title":"Bioinformatics"},{"key":"165_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nbt1358","volume":"26","author":"MW Karaman","year":"2008","unstructured":"Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT et al (2008) A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26:127\u2013132","journal-title":"Nat Biotechnol"},{"key":"165_CR43","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2119\/molmed.2011.00315","volume":"17","author":"MV Karamouzis","year":"2011","unstructured":"Karamouzis MV, Papavassiliou AG (2011) Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigm. Mol Med 17:1133","journal-title":"Mol Med"},{"key":"165_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1300","volume":"4","author":"H Kitano","year":"2004","unstructured":"Kitano H (2004a) Opinion: cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4:227","journal-title":"Nat Rev Cancer"},{"key":"165_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nrg1471","volume":"5","author":"H Kitano","year":"2004","unstructured":"Kitano H (2004b) Biological robustness. Nat Rev Genet 5:826\u2013837","journal-title":"Nat Rev Genet"},{"key":"165_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrd2195","volume":"6","author":"H Kitano","year":"2007","unstructured":"Kitano H (2007) A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 6:202","journal-title":"Nat Rev Drug Discov"},{"key":"165_CR47","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2010","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A et al (2010) DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucleic Acids Res 39:D1035\u2013D1041","journal-title":"Nucleic Acids Res"},{"key":"165_CR48","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1093\/bioinformatics\/btq310","volume":"26","author":"T Korcsm\u00e1ros","year":"2010","unstructured":"Korcsm\u00e1ros T, Farkas IJ, Szalay MS, Rov\u00f3 P, Fazekas D, Spir\u00f3 Z et al (2010) Uniformly curated signaling pathways reveal tissue-specific cross-talks and support drug target discovery. Bioinformatics 26:2042\u20132050","journal-title":"Bioinformatics"},{"key":"165_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.mam.2010.04.001","volume":"31","author":"A Levitzki","year":"2010","unstructured":"Levitzki A, Klein S (2010) Signal transduction therapy of cancer. Mol Aspects Med 31:287\u2013329","journal-title":"Mol Aspects Med"},{"key":"165_CR50","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S1097-2765(00)00132-5","volume":"6","author":"TS Lewis","year":"2000","unstructured":"Lewis TS, Hunt JB, Aveline LD, Jonscher KR, Louie DF, Yeh JM et al (2000) Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol Cell 6:1343\u20131354","journal-title":"Mol Cell"},{"key":"165_CR51","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.febslet.2012.04.029","volume":"586","author":"M Lewitzky","year":"2012","unstructured":"Lewitzky M, Simister PC, Feller SM (2012) Beyond \u2018furballs\u2019 and \u2018dumpling soups\u2019\u2014towards a molecular architecture of signaling complexes and networks. FEBS Lett 586:2740\u20132750","journal-title":"FEBS Lett"},{"key":"165_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nrd1132","volume":"2","author":"AM Manning","year":"2003","unstructured":"Manning AM, Davis RJ (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2:554\u2013565","journal-title":"Nat Rev Drug Discov"},{"key":"165_CR53","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1124\/mol.108.053140","volume":"75","author":"JL McConnell","year":"2009","unstructured":"McConnell JL, Wadzinski BE (2009) Targeting protein serine\/threonine phosphatases for drug development. Mol Pharmacol 75:1249\u20131261","journal-title":"Mol Pharmacol"},{"key":"165_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cgt.2008.73","volume":"16","author":"C Mees","year":"2009","unstructured":"Mees C, Nemunaitis J, Senzer N (2009) Transcription factors: their potential as targets for an individualized therapeutic approach to cancer. Cancer Gene Ther 16:103\u2013112","journal-title":"Cancer Gene Ther"},{"key":"165_CR55","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1074\/jbc.272.8.5141","volume":"272","author":"M Muda","year":"1997","unstructured":"Muda M, Boschert U, Smith A, Antonsson B, Gillieron C, Chabert C et al (1997) Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J Biol Chem 272:5141\u20135151","journal-title":"J Biol Chem"},{"key":"165_CR56","doi-asserted-by":"publisher","first-page":"36989","DOI":"10.1074\/jbc.C300313200","volume":"278","author":"K Nakamura","year":"2003","unstructured":"Nakamura K, Johnson GL (2003) PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J Biol Chem 278:36989\u201336992","journal-title":"J Biol Chem"},{"key":"165_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1742-4658.2012.08522.x","volume":"280","author":"LK Nguyen","year":"2013","unstructured":"Nguyen LK, Matallanas D, Croucher DR, von Kriegsheim A, Kholodenko BN (2013) Signalling by protein phosphatases and drug development: a systems-centred view. FEBS J 280:751\u2013765","journal-title":"FEBS J"},{"key":"165_CR58","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/BJ20082234","volume":"418","author":"KI Patterson","year":"2009","unstructured":"Patterson KI, Brummer T, O\u2019brien PM, Daly RJ (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418:475\u2013489","journal-title":"Biochem J"},{"key":"165_CR59","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1126\/science.278.5346.2075","volume":"278","author":"T Pawson","year":"1997","unstructured":"Pawson T, Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science (80-) 278:2075\u20132080","journal-title":"Science (80-)"},{"key":"165_CR60","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1586\/14737140.4.6.1113","volume":"4","author":"MA Pearson","year":"2004","unstructured":"Pearson MA, Fabbro D (2004) Targeting protein kinases in cancer therapy: a success? Expert Rev Anticancer Ther 4:1113\u20131124","journal-title":"Expert Rev Anticancer Ther"},{"key":"165_CR61","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","volume":"1813","author":"A Plotnikov","year":"2011","unstructured":"Plotnikov A, Zehorai E, Procaccia S, Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta (BBA) Mol Cell Res 1813:1619\u20131633","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"165_CR62","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mrd.20877","volume":"75","author":"CK Prasad","year":"2008","unstructured":"Prasad CK, Mahadevan M, MacNicol MC, MacNicol AM (2008) Mos 3\u2032 UTR regulatory differences underlie species-specific temporal patterns of Mos mRNA cytoplasmic polyadenylation and translational recruitment during oocyte maturation. Mol Reprod Dev 75:1258\u20131268","journal-title":"Mol Reprod Dev"},{"key":"165_CR63","doi-asserted-by":"publisher","first-page":"D1118","DOI":"10.1093\/nar\/gkt1129","volume":"42","author":"C Qin","year":"2013","unstructured":"Qin C, Zhang C, Zhu F, Xu F, Chen SY, Zhang P et al (2013) Therapeutic target database update 2014: a resource for targeted therapeutics. Nucleic Acids Res 42:D1118\u2013D1123","journal-title":"Nucleic Acids Res"},{"key":"165_CR64","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd3478","volume":"10","author":"M Rask-Andersen","year":"2011","unstructured":"Rask-Andersen M, Alm\u00e9n MS, Schi\u00f6th HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10:579\u2013590","journal-title":"Nat Rev Drug Discov"},{"key":"165_CR65","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ (2007) Targeting the Raf\u2013MEK\u2013ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291\u20133310","journal-title":"Oncogene"},{"key":"165_CR66","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.7681221","volume":"259","author":"PJ Rohan","year":"1993","unstructured":"Rohan PJ, Davis P, Moskaluk CA, Kearns M, Krutzsch H, Siebenlist U et al (1993) PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259:1763 (YORK THEN WASHINGTON-)","journal-title":"Science"},{"key":"165_CR67","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc1503","volume":"4","author":"JS Sebolt-Leopold","year":"2004","unstructured":"Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937\u2013947","journal-title":"Nat Rev Cancer"},{"key":"165_CR68","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/gb-2006-7-6-222","volume":"7","author":"JC Simpson","year":"2006","unstructured":"Simpson JC, Pepperkok R (2006) The subcellular localization of the mammalian proteome comes a fraction closer. Genome Biol 7:222","journal-title":"Genome Biol"},{"key":"165_CR69","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1038\/sj.onc.1202989","volume":"18","author":"LM Smith","year":"1999","unstructured":"Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P et al (1999) cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18:6063","journal-title":"Oncogene"},{"key":"165_CR70","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/geno.1996.0638","volume":"38","author":"K Tsukiyama-Kohara","year":"1996","unstructured":"Tsukiyama-Kohara K, Vidal SM, Gingras A-C, Glover TW, Hanash SM, Heng H et al (1996) Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2. Genomics 38:353\u2013363","journal-title":"Genomics"},{"key":"165_CR71","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda \u00c1R (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537\u2013549","journal-title":"Nat Rev Cancer"},{"key":"165_CR72","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/367651a0","volume":"367","author":"Y Ward","year":"1994","unstructured":"Ward Y, Gupta S, Jensen P, Wartmann M, Davis RJ, Kelly K (1994) Control of MAP kinase activation by the mitogen-induced threonine\/tyrosine phosphatase PAC1. Nature 367:651\u2013654","journal-title":"Nature"},{"key":"165_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/scientificamerican0996-62","volume":"275","author":"RA Weinberg","year":"1996","unstructured":"Weinberg RA (1996) How cancer arises. Sci Am 275:62\u201371","journal-title":"Sci Am"},{"key":"165_CR74","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/clpt.2012.96","volume":"92","author":"M Whirl-Carrillo","year":"2012","unstructured":"Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF et al (2012) Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414\u2013417","journal-title":"Clin Pharmacol Ther"},{"key":"165_CR75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12915-014-0088-y","volume":"12","author":"HS Wiley","year":"2014","unstructured":"Wiley HS (2014) Open questions: the disrupted circuitry of the cancer cell. BMC Biol 12:88","journal-title":"BMC Biol"},{"key":"165_CR76","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/biof.52","volume":"35","author":"Z Yao","year":"2009","unstructured":"Yao Z, Seger R (2009) The ERK signaling cascade\u2014views from different subcellular compartments. Biofactors 35:407\u2013416","journal-title":"Biofactors"},{"key":"165_CR77","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/1940-6207.CAPR-10-0008","volume":"3","author":"D Yee","year":"2010","unstructured":"Yee D (2010) Adaptor proteins as targets for cancer prevention. Cancer Prev Res 3:263\u2013265","journal-title":"Cancer Prev Res"},{"key":"165_CR78","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1517\/13543780903321490","volume":"18","author":"H-Y Yong","year":"2009","unstructured":"Yong H-Y, Koh M-S, Moon A (2009) The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 18:1893\u20131905","journal-title":"Expert Opin Investig Drugs"},{"key":"165_CR79","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2174\/157018012799860006","volume":"9","author":"Q Yu","year":"2012","unstructured":"Yu Q, Huang J-F (2012) The analysis of the druggable families based on topological features in the protein\u2013protein interaction network. Lett Drug Des Discov 9:426\u2013430","journal-title":"Lett Drug Des Discov"},{"key":"165_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mce.2009.04.008","volume":"314","author":"E Zehorai","year":"2010","unstructured":"Zehorai E, Yao Z, Plotnikov A, Seger R (2010) The subcellular localization of MEK and ERK\u2014a novel nuclear translocation signal (NTS) paves a way to the nucleus. Mol Cell Endocrinol 314:213\u2013220","journal-title":"Mol Cell Endocrinol"},{"key":"165_CR81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28\u201339","journal-title":"Nat Rev Cancer"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-018-0165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T20:40:09Z","timestamp":1553287209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-018-0165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1007\/s13721-018-0165-1","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"13 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}